Influenza C virus susceptibility to antivirals with different mechanisms of action.
In: Antimicrobial agents and chemotherapy, Jg. 68 (2024-05-02), Heft 5, S. e0172723
academicJournal
Zugriff:
Antiviral susceptibility of influenza viruses was assessed using a high-content imaging-based neutralization test. Cap-dependent endonuclease inhibitors, baloxavir and AV5116, were superior to AV5115 against type A viruses, and AV5116 was most effective against PA mutants tested. However, these three inhibitors displayed comparable activity (EC 50 8-22 nM) against type C viruses from six lineages. Banana lectin and a monoclonal antibody, YA3, targeting the hemagglutinin-esterase protein effectively neutralized some, but not all, type C viruses.
Competing Interests: Andrei A. Ivashchenko and Alexandre V. Ivachtchenko are the cofounders of ChemDiv, managing members of AVISA LCC. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Titel: |
Influenza C virus susceptibility to antivirals with different mechanisms of action.
|
---|---|
Autor/in / Beteiligte Person: | Chesnokov, A ; Ivashchenko, AA ; Matsuzaki, Y ; Takashita, E ; Mishin, VP ; Ivachtchenko, AV ; Gubareva, LV |
Zeitschrift: | Antimicrobial agents and chemotherapy, Jg. 68 (2024-05-02), Heft 5, S. e0172723 |
Veröffentlichung: | Washington, American Society for Microbiology, 2024 |
Medientyp: | academicJournal |
ISSN: | 1098-6596 (electronic) |
DOI: | 10.1128/aac.01727-23 |
Schlagwort: |
|
Sonstiges: |
|